Home
overview

SMi’s inaugural conference on Pharmaceutical Portfolio & Life-cycle Management aims to shed new light on the underlying corporate strategies of pharmaceutical and biotechnology companies. In such a closely competitive environment, the integration of sound management practices incorporating scientific and commercial objectives is critical to the success of an organisation. To address this, the conference will not only examine structuring portfolios and aligning them within corporate frameworks, but will also delve into long term life-cycle management and extending the life of patents. Special emphasis will also be given to innovative marketing approaches and sustaining mature brands.

Confirmed speakers include:

  • Mark Horn, Director, Finance & Portfolio Management, Wyeth
  • Dr Rob Hockney, Director, Global Discovery alliances, AstraZeneca
  • Dr Oliver Steinbach, Head, Technology Management, ALTANA Pharma
  • Dr Tim Sparey, Associate Director, Licensing & External Research, Merck Sharp & Dohme
  • Roger Holdsworth, Associate Director, Portfolio Analysis, UCB Group
  • Melanie McCullagh, Senior Business Development Manager, Antisoma Research

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Marc Sluijs

Marc Sluijs, Business Consultant Pharma & CPG, Agile Software

9:10 STRATEGIC PORTFOLIO MANAGEMENT

Mike Rea

Mike Rea, Chief Executive Officer, Idea Group

  • The company’s role in portfolio management
  • The marketing/scientific relationship
  • Operating in a multi-project, multi-product environment
  • Converting promising product portfolios into highly profitable revenue streams
  • How to prioritise decision-making
  • Current and future industry trends
  • 9:50 GETTING STARTED WITH PORTFOLIO MANAGEMENT

    Mark Horn

    Mark Horn, Director, Finance & Portfolio Management, Wyeth Pharmaceuticals

  • Design of the portfolio process
  • Selection of ranking methodology
  • Critical foundation processes
  • Governance and team structure
  • Advice and insights
  • 10:30 Morning Coffee

    11:00 PUTTING IT INTO PRACTICE

    Sabine Bernotat-Danielowski

    Sabine Bernotat-Danielowski, Executive Director, Decision Analysis, Daiichi-Sankyo

  • Are companies investing enough time and resources into portfolio management?
  • Drivers, roles and challenges
  • Maximising the value of research and development
  • Operating annual reviews with milestone-based projects
  • Establishing information management systems and portfolio management models
  • 11:40 MANAGEMENT TOOLS AND PROCESSES

    Melanie McCullagh

    Melanie McCullagh, Senior Business Development Manager, Antisoma

  • Project evaluation models
  • Portfolio analysis and decision-making
  • Financial tools and supporting techniques for project evaluation
  • Budget vs portfolio prioritisation
  • How can budget information flow between project teams and functional lines?
  • Achieving strategic alignment
  • 12:20 Networking Lunch

    13:50 STRENGTH IN DIVERSITY

    Tim Sparey

    Tim Sparey, Associate Director, Licensing & External Research, Merck Sharp & Dohme

  • Facilitating a combined portfolio to increase revenue streams
  • In-house products as drivers of revenue and development
  • Optimising a mixed portfolio
  • Alliance governance and strategic internal decisions
  • 14:30 THE IMPACT OF LICENSING ON PORTFOLIO MANAGEMENT

    Rob Hockney

    Rob Hockney, Director, Global Discovery Alliances, Astrazeneca Pharmaceuticals Ltd

  • Declining productivity, increased pressure on continued growth and share price
  • Late-stage vs early stage licensing
  • Determining impact and managing risk
  • Benefits and on-going challenges
  • 15:10 Afternoon Tea

    15:40 INTEGRATING TECHNOLOGY INTO COMPANY STRATEGY

    Oliver Steinbach

    Oliver Steinbach, Head, Technology Management, Altana Pharma

  • Evaluating existing and emerging technologies
  • Balancing risk, benefit, costs and alignment with corporate strategy
  • Linking future product developments and technology road-mapping
  • Managing programmes for technology scouting, acquisition and transfer
  • Securing technology implementation, integration and validation
  • 16:20 BEYOND PROJECT PRIORITISATION

    Daniel Smith

    Daniel Smith, Principal, Enrich Consulting

  • Establishing a sound portfolio process
  • Evolving portfolio management from tactical to strategic
  • Portfolio management as a foundation for strategic planning
  • Integrating portfolio management with business development activities
  • 17:00 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Oliver Steinbach

    Oliver Steinbach, Head, Technology Management, Altana Pharma

    9:10 EMPLOYING LIFE-CYCLE MANAGEMENT (LCM)

    Gary Johnson

    Gary Johnson, Managing Director, Inpharmation Ltd

  • The importance of early planning for late-stage product management
  • The analysis of predictive trends
  • Identifying marketing needs and strategies
  • Who in the organisation will be responsible?
  • Determining the length of the life-cycle
  • 9:50 EFFICIENTLY MANAGING A PRODUCT'S LIFE-CYCLE IN A PHARMACEUTICAL COMPANY

    Marc Sluijs

    Marc Sluijs, Business Consultant Pharma & CPG, Agile Software

  • Accelerating new drug development, introduction, and commercialisation
  • Prioritising new product development and introduction (NPD&I)
  • Managing collaboration with outsourced service providers and supply chain networks
  • Providing a change management platform
  • Enabling complete packaging and labelling management
  • Making regulatory submission preparation and communication faster
  • Providing closed-loop compliant handling and corrective action/preventive action system
  • Reducing direct material and operating costs
  • 10:30 Morning Coffee

    11:00 EVALUATION OF LIFE-CYCLE OPPORTUNITES

  • Why do we need to choose between opportunities?
  • Portfolio analysis/management – what can we do and how?
  • Factors affecting valuation
  • Evaluation of new product developments and LCM opportunities – similarities and differences
  • Importance of the overall portfolio view
  • Roger Holdsworth

    Roger Holdsworth, Project Manager, Celltech Therapeutics Ltd

    Roger Holdsworth

    Roger Holdsworth, Associate Director, Portfolio Analysis, UCB Group

    11:40 PRODUCT REFORMULATION

    Martin  Whitaker

    Martin Whitaker, Operations Director, Critical Pharmaceuticals Limited

  • Development and drug delivery options for biologics
  • Extending patent life by releasing improved formulations
  • Development as an integrated marketing strategy
  • A means to effectively protect and differentiate a mature brand
  • 12:20 Networking Lunch

    14:00 THE POWER OF STRONG BRANDING IN LIFE-CYCLE MANAGEMENT

    Johan Heylen

    Johan Heylen, Associate Director, Worldwide Commercial Strategy, GlaxoSmithKline Biologicals

  • Brands as business assets: brand development and it’s role in the pharma industry
  • The Zantac-Tagamet example: optimisation of a blockbuster
  • Patient power: a case study from the vaccine industry
  • 14:40 EXPANDING INDICATIONS FOR EXISTING PRODUCTS

    David Cavalla

    David Cavalla, Chief Executive Officer, Arachnova Ltd

  • Prospecting for new uses: informational and practical approaches
  • Strategies for patent and regulatory protection
  • The role of partnerships in indication expansion
  • Case histories
  • Brand risks within a different therapeutic area: commercial and pricing pressures
  • 15:20 PANEL DISCUSSION

  • What new strategies are companies adopting to prolong the longevity of mature brands?
  • The effectiveness of brand and product line extensions
  • How to maintain a competitive edge in a mature market
  • When should you put an old brand to rest?
  • Johan Heylen

    Johan Heylen, Associate Director, Worldwide Commercial Strategy, GlaxoSmithKline Biologicals

    David Cavalla

    David Cavalla, Chief Executive Officer, Arachnova Ltd

    16:00 Chairman’s Closing Remarks Followed by Afternoon Tea

    +

    Millennium Gloucester Hotel

    Harrington Gardens
    London SW7 4LH
    United Kingdom

    Millennium Gloucester Hotel

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.